Cerebral Angiography Market

Cerebral Angiography Market Outlook (2022 to 2027)

The global cerebral angiography market currently accounts for a valuation of US$ 46 million and is expected to reach US$ 70 million by the end of 2027. Worldwide demand for cerebral angiography is predicted to increase at a robust CAGR of 8.8% from 2022 to 2027.

Demand for cerebral angiography systems is anticipated to rise faster in China than the global average, at 12% CAGR through 2027. In China, the development needed for the entire treatment of cardiovascular disorders in the healthcare industry is aided by solid assistance from government institutions.

Report Attributes	Details
Cerebral Angiography Market Size (2022)	US$ 46 Million
Projected Market Value (2027)	US$ 70 Million
Global Market Growth Rate (2022 to 2027)	8.8% CAGR
Share in Angiography Market (2022)	0.5%
Market Share of China	22%
Key Companies Profiled	GE Healthcare; Samsung Medison; Shimadzu Corp.; Siemens Healthineers; TERUMO Corporation; St. Jude Medical, Inc.; Hitachi Medical Corporation; Koninklijke Philips N.V.; Toshiba Medical Systems Corporation

Revenue Analysis of Cerebral Angiography (2017 to 2021) Vs. Industry Outlook (2022 to 2027)

“Growing Demand for Interventional Angiography Devices for Use in Minimally-invasive Operations”

According to Fact.MR, a market research and competitive intelligence provider, the cerebral angiography market is projected to increase at a CAGR of 8.8% from 2022 to 2027.

A tubing (a lengthy, thin, adaptable tube) is placed into an artery in the arm or leg during cerebral angiography. A technician injects a particular dye into the blood arteries using the tubing, which causes a chemical reaction in the brain. It is a method of delivering x-ray images of the interiors of blood vessels.

The market for cerebral angiography is primarily driven by an increase in cardiovascular disease patients as well as an increase in awareness campaigns, conferences, and funding initiatives. Additionally, the market for cerebral angiography is growing due to the rise in demand for interventional angiography devices in minimally-invasive operations.

Carotid Doppler results are less reliable than those from cerebral angiography. The use of cerebral angiography typically follows the discovery of an abnormality by another test. Acute stroke detection and diagnosis are assisted by angiography. Other methods cannot produce the images that come from cerebral angiography.

What Opportunities Lie Ahead for Key Providers of Cerebral Angiography Devices?

“Innovation in Cerebral Angiography Techniques for Better Diagnosis and Treatment”

Cardiovascular disease treatment with 3D printing is becoming more popular, and it may also be used to prevent disease in the future. Using heart valves that are 3D manufactured from living tissue, aortic valve failure can be addressed without the use of prosthetic valves. The market for cerebral angiography is being driven by healthcare industry innovation and investments.

There are many potential causes of brain aneurysms, including smoking, high blood pressure, and family history. The most frequent causes of a brain aneurysm are an irregular degenerative change in the arterial wall and the pressure created by blood flow pulsations through the brain's arteries. All across the world, brain aneurysms are becoming far more common. The increasing prevalence of cerebral aneurysms is driving market expansion.

A minimally-invasive medical technique involves making a small incision or opening in the body and putting a small device or implant into the body. The acceptance of minimally-invasive surgery equipment has grown significantly in recent years. Because of the little incisions, the patient recovers more quickly and with less pain. Less stress to the muscles, nerves, and tissues, few minor cuts, less bleeding and scarring, restricted pain, quicker oral intake, and shorter hospital stays are all advantages of minimally-invasive procedures.

Over time, there has been a sharp increase in cardiovascular disorders. The growth of the cerebral angiography market is strongly correlated with the rising prevalence of cardiovascular diseases and disorders. Especially in low- and middle-income countries, cardiovascular illnesses are among the most common causes of death worldwide. The market for cerebral angiography is expected to develop tremendously as a result of these causes.

Innovation in cerebral angiography techniques for better diagnosis and treatment has significantly improved the angiography processes. The market for cerebral angiography has a lot of room to develop due to the simplicity and benefits of these technologies.

Market participants are conducting a variety of awareness efforts to enlighten people about the most recent angiography technologies. These programs also aid in educating the general public about angiography-related technology and its advantages. These awareness campaigns are boosting the sales of cerebral angiography products.

What Could Downgrade Demand for Cerebral Angiography Systems?

“Lack of Skilled Professionals & Poor Reimbursement Policies”

The reasons limiting market growth include a lack of skilled professionals, an increase in product recalls, the existence of strict laws related to medical device safety, and poor reimbursement policies.

Furthermore, a barrier to further adoption of cerebral angiography machines is growing product advancements with fresh and inventive qualities that raise the price of equipment. The high cost of the associated devices raises the cost of the treatment, forcing patients to pay exorbitant prices, demonstrating unaffordability.

What are Emerging Market Players Focusing On?

“New Market Players Making Significant Investments in Development of New Technologies that Enhance Patient Outcomes”

Industry start-ups are emphasizing the development of cutting-edge products that are more precise and efficient. New companies are making significant investments in advancements of new technologies, which is anticipated to boost market expansion.

New entrants are concentrating on the introduction of novel cerebral angiography devices, expansion plans, and technological improvements. These advancements are expected to accelerate market growth over the coming years.

• Caristo is an Oxford-based start-up that offers tools for identifying cardiovascular risks. It provides invasive, individualized cardiovascular issue screening using its patented technologies. For modelling cardiac CT scans to detect fat tissue surrounding the coronary arteries known as the Fat Attenuation Index, it uses its patented method of Cardiac Computed Tomography Angiography (CCTA).

Which Region is Expected to Lead Global Market Expansion Going Forward?

“Rapidly Growing Utilization of Cerebral Computed Tomography Techniques in North America”

North America leads the cerebral angiography market. This is because appropriate reimbursement policies support advanced features of cerebral angiography devices.

Growing utilization of cerebral computed tomography techniques, expanding need for effective medical device technologies, rising adoption rates of contemporary & revolutionary medical imaging techniques, and rising prevalence of coronary heart disease are anticipated to drive market expansion in North America.

Country-wise Insights

How is the Market for Cerebral Angiography Evolving in the U.S.?

“Rapid Product Approval Processes and Increasing Angiography Device Usage in the U.S.”

The market in the U.S. is expanding due to the widespread use of minimally-invasive treatments, the availability of reimbursements, rising adoption of cerebral thrombectomy devices, the growing elderly population, a strong network of medical device manufacturers, and the rising number of hospitals with lucrative funding prospects.

The U.S. market is expanding due to rapid product approval processes and increasing angiography device usage as a result of the high volume of angiography screening procedures being conducted.

What Makes China a Lucrative Market for Cerebral Angiography?

“Government Intervention for Betterment of Healthcare Sector Driving Market Value in China”

China accounts for 22% share of the global cerebral angiography market.

Rising prevalence of neurological illnesses, government intervention for the betterment of the healthcare sector, and rising healthcare expenditure are contributing to market expansion in China.

Drivers propelling market expansion in China are continuous improvements in healthcare facilities, growth in the R&D sector, rapid innovations in cerebral angiography equipment, rise in healthcare reforms, and technological developments in stroke management.

Category-wise Insights

Which Technology is Gaining Huge Popularity in This Space?

“Growing Usage of Magnetic Resonance Angiography for Rapid Diagnosis of Heart Diseases”

Based on technology, the cerebral angiography market is divided into, magnetic resonance angiography, computed tomography, ultrasound, nuclear imaging, and X-ray. Magnetic resonance angiography accounts for the highest share of the global market.

Magnetic resonance angiography is one of the most widely utilized diagnostic imaging methods on a global scale. It is frequently seen as essential for identifying, managing, and treating a variety of serious disorders.

The creation of this system is seen as a significant advancement in medical imaging due to the non-invasive, potentially safe, and detailed images of anomalies produced by the human body. As the number of cancer and trauma cases increases globally, so does the utilization of imaging equipment for diagnosis.

Due to its low radiation exposure, MRA is predicted to be the technique that diagnoses heart illness at the fastest rate. Any anatomical plane can be imaged using MRA, and 3D soft tissue contrast is excellent. The detection of coronary artery disease has significantly improved with the development of 3.0T MR imaging. These elements are driving the demand for magnetic resonance angiography.

Which End User is Likely to Contribute the Most to Market Expansion?

“Wide Accessibility of Skilled Medical Personnel in Hospitals”

The cerebral angiography market is segmented into hospitals, diagnostic imaging centers, and others based end user.

The wide range of patients who are diagnosed and treated in hospitals, high resource availability, the high purchasing power of hospitals for cutting-edge technologies, and the availability of supporting healthcare infrastructure and procedures are the main factors contributing to the dominance of the hospital segment.

Accessibility of skilled labor, affordability through government funding, and the growing awareness of the effects of early disease diagnosis can all be attributed to segment growth.

When compared to specialty clinics, hospitals are more accessible and more affordable, which draws a huge patient base of people with cardiovascular illnesses. As a result of trade agreements with manufacturers and suppliers and discounts for large purchases, hospitals' profitability indices also rise.

Competitive Landscape

Companies in the cerebral angiography market are investing in R&D to diversify their product offerings. Partnerships between major industry players are anticipated to fuel market expansion over the coming years.

For instance :

• In 2021, Royal Philips announced its interventional medicine vision by integrating its ground-breaking spectral CT imaging technology into a hybrid Angio CT suite. Through the integration of its distinctive Spectral CT 7500 system and its image-guided therapy system - Azurion with FlexArm into a single interventional suite solution, Philips wants to provide interventionalists with instant table-side access to these two important imaging modalities.

Segmentation of Cerebral Angiography Industry Research

• By Technology :

  • Magnetic Resonance Angiography
  • Computed Tomography
  • Ultrasound
  • Nuclear Imaging
  • X-ray

• By End User :

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa